AI-generated summary
The Berger family from Hamburg suffered from the severe emotional outbursts of their son Lars, who overreacted to stimuli and placed a great strain on everyday family life. After outpatient therapy was not enough, the family decided on three months of inpatient treatment at the Asklepios Clinic in Harburg.
Audio player is loading
Click here to have WELT articles preferred in Google searches.
AI outlook — possibilities, not facts
The new therapy house will shorten the waiting lists for inpatient family treatment in Hamburg.
Likely · Within months
Other Asklepios locations could imitate the model of the shared parent-child therapy house.
Possible · Within years

More and more people in Germany and around the world are using weight loss products such as GLP-1 agonists, originally developed for diabetes, now also advertised for weight loss and longevity. While studies show positive effects on the heart, kidneys and addictive behavior, experts warn of possible psychological addictions and unknown long-term consequences on the brain. The market is growing rapidly, but the abandonment rate is up to 50 percent.

A survey by the General Practitioners Association shows growing dissatisfaction with medical care and its influence on elections. While austerity requirements give rise to fears of deterioration, a municipality in Rhineland-Palatinate is breaking new ground with a municipal practice.
AOK Nordost estimates that requiring a certificate from the first day of illness could increase sickness rates in Mecklenburg-Western Pomerania from the current 7.5 percent to up to 8.2 percent. The basis is a comparison of sick leave data with employer information on actual absences. At the same time, the proportion of long-term illnesses in all days missed is increasing and is now around 40 percent.
In the first half of 2026, according to DAK insurance data, mental illnesses were the most common cause of incapacity to work in Germany, with 184 days of absence per 100 insured people - an increase of nine percent compared to the previous year. Educators and social workers are particularly affected due to a lack of staff, time pressure and emotional stress. The average duration of sick leave is over five weeks and continues to rise.
According to a study, around a tenth of the workforce in Germany works addictively. Experts like Stefan Poppelreuter explain when excessive work becomes an addiction, what warning signs exist and why professional help is important if you lose control.
The Japanese pharmaceutical company Takeda has developed a new drug against narcolepsy called Oveporexton. After approval in the USA, China and Japan, two high-quality studies now demonstrate the high effectiveness and safety of the product.